| Application no. and date | 15155712.1 (espacenet) (Federated) (European Patent Register), 20080703 | | Patent/reg. no. and date | DK/EP 2889310, 20171220 | | Publication date | 20150701 | | Priority no. and date | US 948220 P, 20070706 | | EP pub. no. and date |
EP 2889310 20150701 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/156711 | | Inventor | Brisbane, Charlene E, GlaxoSmithKline
709 Swedeland Road
King of Prussia, PA 19406, US,
Ketkar, Amol Sharad, GlaxoSmithKline
709 Swedeland Road
King of Prussia, PA 19406, US,
Lashmar, Ulla Tove, c/o GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford
Middlesex TW8 9GS, GB | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 9/00 (2006.01) , C07K 16/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Antistofformuleringer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
